North America Infectious Respiratory Disease Diagnostics Market

North America Infectious Respiratory Disease Diagnostics Market Size, Share & Industry Trends Analysis Report By Product Type, By Application, By Sample Type, By Technology (Molecular Diagnostics, Microbiology, Immunoassay), By End-use, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-11395 Publication Date: September-2022 Number of Pages: 135
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The North America Infectious Respiratory Disease Diagnostics Market would witness market growth of -5.8% CAGR during the forecast period (2022-2028).

The demand for diagnostic tests is growing as a result of the rise in lower respiratory infectious disease, which increases the need for early detection. Likewise, the healthcare industry is experiencing an increase in public-private funding for targeted research initiatives. Also, the number of smokers and drinkers, as well as product innovations and development due to technological advancements all over the world is growing continuously and is anticipated to grow further over the forecast period.

In the future, the market's growth rate will be further accelerated by factors such as unhealthy individual lifestyles, rising internet penetration rates, an ageing population base, an increase in pollution levels, product development and commercialization, and rising per capita health care spending. A common condition, respiratory tract infections can be asymptomatic or present as a minor sickness that progresses to cause major problems, hospitalization, or even death.

Respiratory infections are frequently brought on by influenza and other viral diseases such as adenovirus, respiratory syncytial virus, human metapneumovirus, and rhinovirus. To stop and lessen the transmission of the influenza virus, early detection and diagnosis of the viral infection may enable the proper therapy to be started.

Almost 5 million children and nearly 15 million adults in America currently suffer from asthma. Since 1980, the percentage of asthma cases has nearly doubled. Asthma-related deaths affect 5,500 people annually, and over the past 20 years, the rate has risen. Also, due to the rising burden of COVID-19, a strong health care system, and rising rates of whooping cough, influenza, and other respiratory infections, the demand for respiratory disease.

The US market dominated the North America Infectious Respiratory Disease Diagnostics Market by Country in 2021; thereby, achieving a market value of $7.8 billion by 2028. The Canada market is experiencing a CAGR of -3.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of -4.5% during (2022 - 2028).

Based on Product Type, the market is segmented into Consumables, Instruments (Imaging Tests, Respiratory Measurement Devices, and Others), Services. Based on Application, the market is segmented into SARS/COVID 19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, and Others. Based on Sample Type, the market is segmented into Saliva, Anterior Nasal Region, Blood, Nasopharyngeal Swabs (NPS), and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Microbiology, Immunoassay, and Others. Based on End-use, the market is segmented into Diagnostic Laboratories, Hospitals, and Physician Offices & Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Global Infectious Respiratory Disease Diagnostics Market is Estimated to reach $ 37.2 Billion by 2028, at a CAGR of -5.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Qiagen N.V., Bio-Rad Laboratories, Inc., Danaher Corporation, Quidel Corporation

Scope of the Study

Market Segments Covered in the Report:

By Product Type

  • Consumables
  • Instruments
    • Imaging Tests
    • Respiratory Measurement Devices
    • Others
  • Services

By Application

  • Influenza
  • RSV (Respiratory Syncytial Virus)
  • Tuberculosis
  • Streptococcus Testing
  • Others

By Sample Type

  • Saliva
  • Anterior Nasal Region
  • Blood
  • Nasopharyngeal Swabs (NPS)
  • Others

By Technology

  • Molecular Diagnostics
  • Microbiology
  • Immunoassay
  • Others

By End Use

  • Diagnostic Laboratories
  • Hospitals
  • Physician Offices & Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Siemens Healthineers AG (Siemens AG)
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Quidel Corporation
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo